[Primary chemotherapy in soft tissue sarcomas considered inoperable]

Sem Hop. 1983 May 12;59(19):1441-4.
[Article in French]

Abstract

Fourteen adult patients with inoperable soft tissue sarcoma (with metastases in 4 cases) received chemotherapy as primary treatment. Nine cases were treated by CYVADIC (cyclophosphamide, vincristin, doxorubicin, DTIC) and five cases by DECAV (DTIC, cyclophosphamide, cis-platinum, doxorubicin, vindesine). An objective response was obtained in 7 cases (1 complete remission and 6 regressions greater than 50%) and stabilization in 4 cases. Seven patients became operable after 2 to 6 courses of chemotherapy and a complete resection could be performed in 6 cases. The duration of the response was 2 to 39 months. Toxicity with both combinations was acceptable. We conclude that chemotherapy can provide initial tumor reduction and permit subsequently less radical surgery.

Publication types

  • Case Reports
  • Comparative Study
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols*
  • Cisplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sarcoma / drug therapy*
  • Sarcoma / pathology
  • Sarcoma / surgery
  • Soft Tissue Neoplasms / drug therapy*
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / surgery
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives
  • Vincristine / administration & dosage
  • Vindesine

Substances

  • Antineoplastic Agents
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Vindesine

Supplementary concepts

  • CYVADIC protocol
  • DECAV protocol